SCHEMBL22619087

SCHEMBL22619087

O=S(=O)(Nc1cccc(I)c1)c1cnco1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 1/20 0.44
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
PFKFB3 Q16875 3/20 0.40
KMT2A Q03164 3/20 0.40
POLB P06746 1/20 0.40
PFKFB4 Q16877 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
LMNA P02545 1/20 0.37
TDO2 P48775 1/20 0.37
ITGA1 P56199 1/20 0.36
HTR6 P50406 2/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22928030 0.80 BRS3 (0.44) EDNRAKMT2APOLBCYP3A4LMNA
SCHEMBL22619083 0.78 PARP1 (0.45) POLBLMNAITGA1HTR6CYP19A1
SCHEMBL22619084 0.74 ITGA1 (0.36) PTGS1PTGS2KMT2AITGA1HTR6
SCHEMBL15314389 0.72 KMT2A (0.65) PTGS1PTGS2KMT2APOLBGAA
SCHEMBL22618998 0.72 CYP19A1 (0.43) PTGS1PTGS2KMT2APOLBLMNA
SCHEMBL22618989 0.72 HPGD (0.43) PTGS1PTGS2KMT2ALMNAITGA1
SCHEMBL22619002 0.71 LMNA (0.71) PTGS1PTGS2KMT2APOLBCYP3A4
SCHEMBL22619088 0.71 PTGS1 (0.38) PTGS1PTGS2KMT2ACYP3A4TDO2
SCHEMBL2690296 0.70 KEAP1 (0.66) KMT2APOLBLMNAITGA1HTR6
SCHEMBL22619001 0.70 PFKFB3 (0.41) PTGS1PTGS2PFKFB3KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3733670-A1 TETRAHYDROPYRROLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF Mediconns (Shanghai) Biopharmaceutical Co., Ltd (CN) 2020-11-04 EP disclosed